iBio Inc (IBIO)
1.76
+0.04
(+2.33%)
USD |
NYAM |
Apr 26, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
iBio Cash from Operations (Quarterly): -4.706M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.706M |
| September 30, 2023 | -5.34M |
| June 30, 2023 | -4.97M |
| March 31, 2023 | -3.872M |
| December 31, 2022 | -7.635M |
| September 30, 2022 | -13.96M |
| June 30, 2022 | -11.50M |
| March 31, 2022 | -5.944M |
| December 31, 2021 | -10.69M |
| September 30, 2021 | -9.347M |
| June 30, 2021 | -7.226M |
| March 31, 2021 | -7.349M |
| December 31, 2020 | -8.419M |
| September 30, 2020 | -7.07M |
| June 30, 2020 | -3.867M |
| March 31, 2020 | -3.786M |
| December 31, 2019 | -3.405M |
| September 30, 2019 | -2.287M |
| June 30, 2019 | -4.392M |
| March 31, 2019 | -4.135M |
| December 31, 2018 | -4.67M |
| September 30, 2018 | -0.778M |
| June 30, 2018 | -3.375M |
| March 31, 2018 | -3.50M |
| December 31, 2017 | -3.588M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.017M |
| June 30, 2017 | -3.765M |
| March 31, 2017 | -3.561M |
| December 31, 2016 | -3.564M |
| September 30, 2016 | -2.273M |
| June 30, 2016 | -2.822M |
| March 31, 2016 | -2.436M |
| December 31, 2015 | -1.667M |
| September 30, 2015 | -1.147M |
| June 30, 2015 | -1.207M |
| March 31, 2015 | -1.325M |
| December 31, 2014 | -1.623M |
| September 30, 2014 | -0.57M |
| June 30, 2014 | -0.684M |
| March 31, 2014 | -1.227M |
| December 31, 2013 | -1.294M |
| September 30, 2013 | -0.911M |
| June 30, 2013 | -0.909M |
| March 31, 2013 | -1.246M |
| December 31, 2012 | -1.404M |
| September 30, 2012 | -1.29M |
| June 30, 2012 | -1.040M |
| March 31, 2012 | -2.957M |
| December 31, 2011 | -0.7841M |
| September 30, 2011 | -1.228M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.96M
Minimum
Sep 2022
-2.287M
Maximum
Sep 2019
-6.619M
Average
-5.944M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
| Lixte Biotechnology Holdings Inc | -0.9021M |
| PAVmed Inc | -11.87M |
| Avalo Therapeutics Inc | -2.766M |
| Imunon Inc | -3.772M |
| Ocugen Inc | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.005M |
| Free Cash Flow | -18.89M |
| Free Cash Flow Per Share (Quarterly) | -2.536 |
| Free Cash Flow Yield | -938.5% |